Indian pharma market grew by 13.7% in July 2021: Ind-Ra
Demand normalisation post the second wave contributed to the steady growth
Demand normalisation post the second wave contributed to the steady growth
India business is growing as per projections; whereas US business will bounce back soon.
Adjusted PAT declined 18.8% YoY
Subscribe To Our Newsletter & Stay Updated